[go: up one dir, main page]

JPWO2019169004A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019169004A5
JPWO2019169004A5 JP2020545159A JP2020545159A JPWO2019169004A5 JP WO2019169004 A5 JPWO2019169004 A5 JP WO2019169004A5 JP 2020545159 A JP2020545159 A JP 2020545159A JP 2020545159 A JP2020545159 A JP 2020545159A JP WO2019169004 A5 JPWO2019169004 A5 JP WO2019169004A5
Authority
JP
Japan
Prior art keywords
seq
acid sequence
protein
capsid
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020545159A
Other languages
English (en)
Japanese (ja)
Other versions
JP7498665B2 (ja
JP2021515548A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/019861 external-priority patent/WO2019169004A1/en
Publication of JP2021515548A publication Critical patent/JP2021515548A/ja
Publication of JPWO2019169004A5 publication Critical patent/JPWO2019169004A5/ja
Priority to JP2024088641A priority Critical patent/JP2024115558A/ja
Application granted granted Critical
Publication of JP7498665B2 publication Critical patent/JP7498665B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020545159A 2018-02-27 2019-02-27 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用 Active JP7498665B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024088641A JP2024115558A (ja) 2018-02-27 2024-05-31 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用

Applications Claiming Priority (29)

Application Number Priority Date Filing Date Title
US201862635964P 2018-02-27 2018-02-27
US201862635968P 2018-02-27 2018-02-27
US62/635,964 2018-02-27
US62/635,968 2018-02-27
US201862663788P 2018-04-27 2018-04-27
US201862663797P 2018-04-27 2018-04-27
US62/663,797 2018-04-27
US62/663,788 2018-04-27
US201862667587P 2018-05-06 2018-05-06
US62/667,587 2018-05-06
US201862667881P 2018-05-07 2018-05-07
US201862667888P 2018-05-07 2018-05-07
US62/667,888 2018-05-07
US62/667,881 2018-05-07
US201862677471P 2018-05-29 2018-05-29
US201862667585P 2018-05-29 2018-05-29
US201862677474P 2018-05-29 2018-05-29
US62/677,471 2018-05-29
US62/677,474 2018-05-29
US62/667,585 2018-05-29
US201862703673P 2018-07-26 2018-07-26
US201862703670P 2018-07-26 2018-07-26
US62/703,673 2018-07-26
US62/703,670 2018-07-26
US201862722382P 2018-08-24 2018-08-24
US201862722388P 2018-08-24 2018-08-24
US62/722,388 2018-08-24
US62/722,382 2018-08-24
PCT/US2019/019861 WO2019169004A1 (en) 2018-02-27 2019-02-27 Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024088641A Division JP2024115558A (ja) 2018-02-27 2024-05-31 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用

Publications (3)

Publication Number Publication Date
JP2021515548A JP2021515548A (ja) 2021-06-24
JPWO2019169004A5 true JPWO2019169004A5 (es) 2022-02-18
JP7498665B2 JP7498665B2 (ja) 2024-06-12

Family

ID=67809202

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020545159A Active JP7498665B2 (ja) 2018-02-27 2019-02-27 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用
JP2024088641A Pending JP2024115558A (ja) 2018-02-27 2024-05-31 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024088641A Pending JP2024115558A (ja) 2018-02-27 2024-05-31 新規アデノ随伴ウイルス(aav)ベクター、低減されたカプシド脱アミド化を有するaavベクター、およびその使用

Country Status (14)

Country Link
US (1) US12416016B2 (es)
EP (1) EP3768695A4 (es)
JP (2) JP7498665B2 (es)
KR (1) KR102848518B1 (es)
CN (2) CN112236443B (es)
AU (1) AU2019228504B2 (es)
BR (1) BR112020017278A2 (es)
CA (1) CA3091795A1 (es)
CL (1) CL2020002201A1 (es)
IL (1) IL276860A (es)
MA (1) MA52087A (es)
MX (1) MX2020008932A (es)
SG (1) SG11202007942YA (es)
WO (1) WO2019169004A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL292830B2 (en) 2015-09-28 2023-06-01 Univ Florida Methods and compositions for stealth virus antibody vectors
CN112236443B (zh) * 2018-02-27 2025-02-07 宾夕法尼亚州大学信托人 新颖腺相关病毒(aav)载体、具有降低的衣壳脱酰胺化的aav载体及其用途
AU2019247746B2 (en) 2018-04-03 2024-08-15 Ginkgo Bioworks, Inc. Antibody-evading virus vectors
AU2019247748A1 (en) 2018-04-03 2020-10-08 Ginkgo Bioworks, Inc. Antibody-evading virus vectors
US12359181B2 (en) 2018-12-21 2025-07-15 The University Of North Carolina At Chapel Hill Optimized GALC genes and expression cassettes and their use
MX2021011468A (es) 2019-03-21 2021-12-15 Vectores de virus adenoasociados recombinantes.
WO2020223232A1 (en) 2019-04-29 2020-11-05 The Trustees Of The University Of Pennsylvania Novel aav capsids and compositions containing same
WO2021076925A1 (en) 2019-10-17 2021-04-22 Stridebio, Inc. Adeno-associated viral vectors for treatment of niemann-pick disease type c
WO2021080991A1 (en) * 2019-10-21 2021-04-29 The Trustees Of The University Of Pennsylvania Aav3b variants with improved production yield and liver tropism
WO2021138381A1 (en) * 2020-01-03 2021-07-08 Sarepta Therapeutics, Inc. Methods for analyzing aav capsid proteins
EP4117735A4 (en) * 2020-03-09 2024-04-10 University of Massachusetts Gene replacement therapy for foxg1 syndrome
MX2022016528A (es) 2020-06-17 2023-06-02 Univ Pennsylvania Composiciones y métodos para el tratamiento de pacientes de terapia génica.
WO2022015715A1 (en) 2020-07-13 2022-01-20 The Trustees Of The University Of Pennsylvania Compositions useful for treatment of charcot-marie-tooth disease
IL300717A (en) 2020-08-19 2023-04-01 Sarepta Therapeutics Inc ADENO-related virus vectors for the treatment of RETT syndrome
TW202229315A (zh) * 2020-10-18 2022-08-01 賓州大學委員會 改良的腺相關病毒(aav)載體及其用途
MX2023008826A (es) 2021-02-01 2023-09-15 Regenxbio Inc Terapia génica para lipofuscinosis neuronal ceroidea.
AU2022258312A1 (en) 2021-04-12 2023-10-26 The Trustees Of The University Of Pennsylvania Compositions useful for treating spinal and bulbar muscular atrophy (sbma)
WO2023081807A1 (en) * 2021-11-04 2023-05-11 The Trustees of the University of Pennsylvania Penn Center for Innovation Compositions and methods for reducing pcsk9 levels in a subject
WO2023133584A1 (en) 2022-01-10 2023-07-13 The Trustees Of The University Of Pennsylvania Compositions useful in treatment of metachromatic leukodystrophy
WO2023133574A1 (en) 2022-01-10 2023-07-13 The Trustees Of The University Of Pennsylvania Compositions and methods useful for treatment of c9orf72-mediated disorders
WO2023196892A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors
EP4661965A1 (en) * 2023-03-25 2025-12-17 Duke University Compositions comprising kidney-tropic aavs and methods of use thereof
WO2025250683A1 (en) * 2024-05-29 2025-12-04 Tenaya Therapeutics, Inc. Adeno-associated virus with engineered capsid

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US6268213B1 (en) 1992-06-03 2001-07-31 Richard Jude Samulski Adeno-associated virus vector and cis-acting regulatory and promoter elements capable of expressing at least one gene and method of using same for gene therapy
US5869305A (en) 1992-12-04 1999-02-09 The University Of Pittsburgh Recombinant viral vector system
US6204059B1 (en) 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US6093570A (en) 1995-06-07 2000-07-25 The University Of North Carolina At Chapel Hill Helper virus-free AAV production
DE69824859T2 (de) 1997-04-14 2005-08-04 Cell Genesys, Inc., Foster City Methoden zur erhöhung der effizienz rekombinanter aav produkte
EP1080218A1 (en) 1998-05-27 2001-03-07 University of Florida Method of preparing recombinant adeno-associated virus compositions by using an iodixanol gradient
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
AU780231B2 (en) 1998-11-10 2005-03-10 University Of North Carolina At Chapel Hill, The Virus vectors and methods of making and administering the same
AU781958C (en) 1999-08-09 2006-03-30 Targeted Genetics Corporation Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs
AU2001268149B2 (en) 2000-06-01 2005-08-18 University Of North Carolina At Chapel Hill Methods and compounds for controlled release of recombinant parvovirus vectors
SG10201506627PA (en) 2001-11-13 2015-10-29 Univ Pennsylvania A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
US20070015238A1 (en) 2002-06-05 2007-01-18 Snyder Richard O Production of pseudotyped recombinant AAV virions
WO2004083441A2 (en) * 2003-03-19 2004-09-30 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Random peptide library displayed on aav vectors
US8005620B2 (en) 2003-08-01 2011-08-23 Dna Twopointo Inc. Systems and methods for biopolymer engineering
WO2005012877A2 (en) 2003-08-01 2005-02-10 Dna Twopointo Inc. Systems and methods for antibody engineering
CN102212558B (zh) * 2003-09-30 2016-08-03 宾夕法尼亚大学托管会 腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
US20060246079A1 (en) 2003-11-14 2006-11-02 Morrow Phillip R Neutralizing human antibodies to anthrax toxin
CN101203613B (zh) * 2005-04-07 2012-12-12 宾夕法尼亚大学托管会 增强腺相关病毒载体功能的方法
JP4495210B2 (ja) 2005-06-09 2010-06-30 パナソニック株式会社 振幅誤差補償装置及び直交度誤差補償装置
US7588772B2 (en) 2006-03-30 2009-09-15 Board Of Trustees Of The Leland Stamford Junior University AAV capsid library and AAV capsid proteins
US20130023033A1 (en) 2010-03-29 2013-01-24 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
US8628966B2 (en) 2010-04-30 2014-01-14 City Of Hope CD34-derived recombinant adeno-associated vectors for stem cell transduction and systemic therapeutic gene transfer
PL3198018T3 (pl) * 2014-09-24 2021-07-19 City Of Hope Warianty wektora wirusa związanego z adenowirusami dla wysokiej skuteczności edycji genomu i jego sposoby
WO2016086227A2 (en) * 2014-11-26 2016-06-02 The Regents Of The University Of California Therapeutic compositions comprising transcription factors and methods of making and using the same
AU2016344065A1 (en) 2015-10-28 2018-05-10 The Trustees Of The University Of Pennsylvania Intrathecal administration of adeno-associated-viral vectors for gene therapy
EP3387138B1 (en) 2015-12-11 2022-01-26 The Trustees Of The University Of Pennsylvania Scalable purification method for aav9
EP4215605A1 (en) 2015-12-11 2023-07-26 The Trustees of The University of Pennsylvania Scalable purification method for aav8
WO2017100674A1 (en) 2015-12-11 2017-06-15 The Trustees Of The University Of Pennsylvania Scalable purification method for aav1
BR112018071156A2 (pt) 2016-04-15 2019-03-12 The Trustees Of The University Of Pennsylvania terapia de gene para tratar mucopolissacaridose tipo ii
IL298604A (en) * 2016-04-15 2023-01-01 Univ Pennsylvania Novel aav8 mutant capsids and compositions containing same
EP3491008A2 (en) * 2016-07-26 2019-06-05 BioMarin Pharmaceutical Inc. Novel adeno-associated virus capsid proteins
ES2863674T3 (es) * 2016-08-15 2021-10-11 Genzyme Corp Métodos para detectar AAV
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
SG10201912973XA (en) 2017-02-28 2020-03-30 Univ Pennsylvania Adeno-associated virus (aav) clade f vector and uses therefor
CN112236443B (zh) * 2018-02-27 2025-02-07 宾夕法尼亚州大学信托人 新颖腺相关病毒(aav)载体、具有降低的衣壳脱酰胺化的aav载体及其用途

Similar Documents

Publication Publication Date Title
JPWO2019169004A5 (es)
JP2020510429A5 (es)
CN101528916B (zh) 规模可调的aav生产方法
JPWO2019168961A5 (es)
US6593123B1 (en) Large-scale recombinant adeno-associated virus (rAAV) production and purification
US7220577B2 (en) Modified AAV
JP7601339B2 (ja) Aavを産生する方法
FI3589730T3 (fi) Kladin f adenoassosioitunut virus (aav) -vektori ja sen käyttötapoja
JP2018108113A5 (es)
CN110997912A (zh) 用于改进的细胞转染和/或rAAV载体生产的增强剂
US12398403B2 (en) Methods for the manufacture of recombinant viral vectors
JPWO2020223232A5 (es)
AU2019231711A1 (en) AAV chimeras
JPWO2020223236A5 (es)
JPWO2020223231A5 (es)
JP7481755B2 (ja) 組換えパルボウイルスベクターならびにその作製および使用方法
US20240084268A1 (en) Method for purifying recombinant viral particles
AU2003272672B2 (en) High titer recombinant AAV production
CN116063404B (zh) 可提高AAV包装能力的衣壳蛋白MutD及其应用
AR123838A1 (es) Vector mejorado de virus adenoasociado (aav) y usos de este
JPWO2022036220A5 (es)
US20250179520A1 (en) Recombinant aav vectors and uses thereof
JPWO2022094180A5 (es)
CN116063405B (zh) 可提高AAV病毒包装能力的衣壳蛋白突变体MutC及其应用
AR123956A1 (es) Cápsides de aav y composiciones que las contienen